Autonomously functioning thyroid nodules are not associated with BRAF mutations

Clinical Endocrinology

Volumn 60, Issue 3, 2004, Pages 394-396

  Kimura, Edna T ^a,b   Vanvooren, Vanessa ^a,b   Van Sande, Jacqueline ^a,b   Nikiforov, Yuri E ^a,b   Fagin, James A ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SERINE THREONINE KINASE; THYROTROPIN; THYROTROPIN RECEPTOR;

BENIGN TUMOR; BRAF GENE; ENZYME ACTIVATION; GENE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC SCREENING; HORMONAL REGULATION; HUMAN; LETTER; NONHUMAN; PAPILLOMA; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SOMATIC MUTATION; THYROID DISEASE; THYROID NODULE;

EID: 1542329531     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2004.01991.x     Document Type: Letter

References (10)

1. Cohen, Y., Xing, M., Mambo, E., Guo, Z., Wu, G., Trink, B., Beller, U., Westra, W.H., Ladenson, P.W. & Sidransky, D. (2003) BRAF mutation in papillary thyroid carcinoma. Journal of the National Cancer Institute, 95, 625-627.
2. Corvilain, B., Van Sande, J., Dumont, J.E. & Vassart, G. (2001) Somatic and germline mutations of the TSH receptor and thyroid diseases. Clinical Endocrinology, 55, 143-158.
3. Davies, H., Bignell, G.R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M.J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B.A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G.J., Bigner, D.D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J.W., Leung, S.Y., Yuen, S.T., Weber, B.L., Seigler, H.F., Darrow, T.L., Paterson, H., Marais, R., Marshall, C.J., Wooster, R., Stratton, M.R. & Futreal, P.A. (2002) Mutations of the BRAF gene in human cancer. Nature, 417, 949-954.
4. Kimura, E.T., Nikiforova, M.N., Zhu, Z., Knauf, J.A., Nikiforov, Y.E. & Fagin, J.A. (2003) High prevalence of BRAF mutations in thyroid cancer genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Research, 63, 1454-1457.
5. Namba, H., Nakashima, M., Hayashi, T., Hayashida, N., Maeda, S., Rogounovitch, T.I., Ohtsuru, A., Saenko, V.A., Kanematsu, T. & Yamashita, S. (2003) Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. Journal of Clinical Endocrinology and Metabolism, 88, 4393-4397.
6. Nikiforova, M.N., Kimura, E.T., Gandhi, M., Biddinger, P.W., Knauf, J.A., Basolo, F., Zhu, Z., Giannini, R., Salvatore, G., Fusco, A., Santoro, M., Fagin, J.A. & Nikiforov, Y.E. (2003) BRAF Mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. Journal of Clinical Endocrinology and Metabolism, 88, 5399-5404.
7. Ribeiro-Neto, F., Urbani, J., Lemee, N., Lou, L. & Altschuler, D.L. (2002) On the mitogenic properties of Rap1b: cAMP-induced G(1)/S entry requires activated and phosphorylated Rap1b. Proceedings of the National Academy of Sciences of the USA, 99, 5418-5423.
8. Soares, P., Trovisco, V., Rocha, A.S., Lima, J., Castro, P., Preto, A., Maximo, V., Botelho, T., Seruca, R. & Sobrinho-Simoes, M. (2003) BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene, 22, 4578-4580.
9. Vandeput, F., Perpete, S., Coulonval, K., Lamy, F. & Dumont, J.E. (2003) Role of the different mitogen-activated protein kinase subfamilies in the stimulation of dog and human thyroid epithelial cell proliferation by cyclic adenosine 5′-monophosphate and growth factors. Endocrinology, 4, 1341-1349.
10. Xu, X., Quiros, R.M., Gattuso, P., Ain, K.B. & Prinz, R.A. (2003) High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Research, 63, 4561-4567.